Monovisc

Monovisc is a pioneering single-injection treatment designed to provide long-lasting relief from knee joint pain caused by osteoarthritis (OA). This viscosupplement is formulated with ultra-pure, non-avian hyaluronic acid, mimicking the hyaluronic acid naturally found in a healthy knee. The unique composition of the product, which is both biocompatible and resorbable, allows for a single injection to offer pain relief that can last for up to 6 months. In the United States, Monovisc is specifically approved for the treatment of pain associated with OA of the knee. In Canada and the EEA, Monovisc’s indications include acting as a viscoelastic supplement or replacement for synovial fluid in knee joints, particularly suited for the symptoms of knee joint dysfunctions like OA.

Benefits of Monovisc:

• Monovisc is a single-injection treatment, offering convenience and eliminating the need for multiple visits to the physician
• the product is composed of a highly concentrated form of HA derived from non-animal sources, minimizing the risk of allergies or patient intolerances
• injections offer extended pain relief lasting through 26 weeks

Scope of Monovisc:

• lubrication and mechanical support of the knee
• pain relief from knee joint pain caused by osteoarthritis 
• supplement or replacement of synovial fluid in knee joints

The product is not suitable for independent use and can be used only by certified cosmetologists.